Table 1.
Demographic parameters.
| PD | HD | |||
|---|---|---|---|---|
| Diabetic patients (n=24) | Nondiabetic patients (n=23) | Diabetic patients (n=30) | Nondiabetic patients (n=27) | |
|
| ||||
| Age (y) | 56.92 (19.4) | 37.83 (38.21) | 54.75 (24.587) | 59.4 (33.45) |
| M:F (no. of patients) | 13/11 | 11/12 | 9/21 | 10/16 |
| Time on dialysis (mo) | 69.1 (23.98) | 30.826(28.24) | 33.3 (25.8) | 80.7 (93.33) |
| CAPD/CCPD | 5/19 | 7/16 | ||
| Route of EPO | Subcutaneous | Subcutaneous | Intravenous | Intravenous |
| Using ACEi or ARBs | 17 (70.83%) | 15 (65.2%) | 10 (33.3%) | 5 (18.51%) |
| Using statins | 14 (58.33%) | 10 (43.4%) | 22 (73.3%) | 14 (51.85%) |
PD: Peritoneal dialysis, HD: hemodialysis, M:F: male/female ratio, CAPD continuous ambulatory peritoneal dialysis, CCPD: continuous cycler peritoneal dialysis, EPO: erythropoietin, ACEi: angiotensin-converting enzyme inhibitor, ARB: angiotensin receptor blocker.